The Becker Lab is expanding the material properties of 3D-printed poly (propylene fumarate-co-propylene succinate) copolyesters and their use in drug delivery applications. In their recent work, "Controlled Transdermal Delivery of Dexamethasone for Pain Management via Photochemically 3D-Printed Bioresorbable Microneedle Arrays", Becker lab members are fabricating poly(propylene fumarate-co-propylene succinate) oligomers into DXM-loaded, bioresorbable MAPs via continuous liquid interface production 3D printing. Read more about this research in Advanced Healthcare Materials, available here